1 – 10 of 15
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2009
- 
                        Mark
        The plasma concentration of activated protein C appears normal in patients with haemophilia
    
    - Contribution to journal › Article
 
- 2008
- 
                        Mark
        ASPECTS OF FLUID THERAPY: An experimental study of the effects of systemic inflammation, microvascular permeability, blood pressure and plasma volume
    
    - Thesis › Doctoral thesis (compilation)
 
- 2006
- 
                        Mark
        Early identification of acute myocardial infarction by activated protein C-protein C inhibitor complex.
    
    - Contribution to journal › Article
 
- 2005
- 
                        Mark
        Selective modulation of protein C affinity for EPCR and phospholipids by Gla domain mutation
    
    - Contribution to journal › Article
 
- 
                        Mark
        Synthesis, Function, and Inactivation of Blood Coagulation Factor V.
    
    - Thesis › Doctoral thesis (monograph)
 
- 2003
- 
                        Mark
        The regulation of factor Va activity by activated protein C -Importance of the individual activated protein C cleavage sites in factor Va
    (2003)- Thesis › Doctoral thesis (compilation)
 
- 2001
- 
                        Mark
        Development of a Method to Measure Plasma Levels of Activated Protein C in Complex with Protein C Inhibitor
    (2001)- Thesis › Doctoral thesis (compilation)
 
- 2000
- 
                        Mark
        Protein Interactions Involving the Laminin G-type Domains of Vitamin K-dependent Protein S.
    (2000)- Thesis › Doctoral thesis (compilation)
 
- 1998
- 
                        Mark
        Pro- and anticoagulant activities of factor V
    (1998)- Thesis › Doctoral thesis (compilation)
 
- 1997
- 
                        Mark
        The factor VR5O6Q mutation causing APC resistance is highly prevalent amongst unselected outpatients with clinically suspected deep venous thrombosis
    
    - Contribution to journal › Article
 
